Rx Imports Could Be "Good For The Country," Caremark Suggests
This article was originally published in The Pink Sheet Daily
Caremark sees the potential for legalized wholesale imports from Canada to offer an opportunity analogous to the current profit and savings impact of generic drugs
You may also be interested in...
The limited supply of drugs coming from Canada under a legalized importation system would have little impact on U.S. prices, Caremark CEO Crawford says at PCMA annual meeting. Importation would require PBMs to decide how to distribute lower-priced Canadian products among their clients, he says.
In sign of how much has changed in four years, industry might be better off if Biden takes CAP’s advice and launches ‘march-in’ actions to address pricing of COVID products.